Ingevity Corporation (NGVT) SEC Filings & Earnings Calls
EquiReason read 18 Ingevity Corporation SEC filings in the last 12 months. Latest: 10-Q on 2026-07-30 — Ingevity reported Q2 2026 net sales of $314.1 million, down 5% year-over-year, but adjusted EBITDA rose 14% to $115 million, and full-year guidance was raised..
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
- Market cap
- 2.4B
- P/E TTM
- 46.4
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 4 Nov, in 11 days
Every filing, read
last 12 months · SECWhat happened, the numbers inside, guidance and risks. The original is one click away.
30 Jul 202610-QIngevity reported Q2 2026 net sales of $314.1 million, down 5% year-over-year, but adjusted EBITDA rose 14% to $115 million, and full-year guidance was raised.earningsopen
Figures in the filing · each found in the filing text
| Net sales · consolidated · Q2-2026 | $314M | -5% y/y |
| Net sales · consolidated · H1-2026 | $572M | -1% y/y |
| Gross profit · consolidated · Q2-2026 | $139M | +9% y/y |
| Gross profit · consolidated · H1-2026 | $255M | +7% y/y |
| Net income (loss) from continuing operations · continuing_operations · Q2-2026 | $40M | -128% y/y |
| Net income (loss) from continuing operations · continuing_operations · H1-2026 | $63M | -156% y/y |
| Adjusted EBITDA from continuing operations · continuing_operations · Q2-2026 | $115M | +14% y/y |
| Adjusted EBITDA from continuing operations · continuing_operations · H1-2026 | $207M | +7% y/y |
| Performance Materials net sales · performance_materials · Q2-2026 | $161M | +4% y/y |
| Performance Materials net sales · performance_materials · H1-2026 | $316M | +5% y/y |
Guidance
2026 adjusted EBITDA guided $380M-$400M, raised from prior; net sales guided $1.05B-$1.15B
Management raised full-year adjusted EBITDA guidance to $380-400 million, citing strong first-half execution and results across the portfolio.
Risks flagged
Litigation liability
“On April 1, 2026, we paid $113.2 million to resolve matters related to the litigation with BASF Corporation, consisting of: (1) the judgment, plus post-judgment interest, in the amount of $97.0 million and (2) $16.2 million to resolve BASF's claim for attorneys' fees and costs.” · word for word
Asset impairment risk
“we recorded a non-cash impairment charge of $32.1 million.” · word for word
Adverse conditions in automotive market
“adverse conditions in the automotive market have and may continue to negatively impact demand for our automotive carbon products” · word for word
Tariff and trade policy risk
“we are exposed to risks related to our international sales and operations, including recent changes in tariffs and trade policies” · word for word
29 Jul 20268-K · 2.02Ingevity reports Q2 2026: net sales $314.1M (-5% YoY, +5% ex-Road Markings); adj. EBITDA $115.0M (+14% YoY); raises FY adj. EBITDA guidance to $380-400M; completed Road Markings sale for ~$63M.earningsopen
Figures in the filing · each found in the filing text
| Net sales · Q2-2026 | $314M | -5% y/y |
| Net income from continuing operations · Q2-2026 | $40M | |
| Adjusted EBITDA · Q2-2026 | $115M | +14% y/y |
| Adjusted EBITDA margin · Q2-2026 | 36.6% | |
| Performance Materials sales · Performance Materials · Q2-2026 | $161M | +4% y/y |
| Performance Materials EBITDA margin · Performance Materials · Q2-2026 | 53.6% | |
| Pavement Technologies sales · Pavement Technologies · Q2-2026 | $104M | -22% y/y |
| Pavement Technologies EBITDA margin · Pavement Technologies · Q2-2026 | 24.4% | |
| Advanced Polymer Technologies sales · Advanced Polymer Technologies · Q2-2026 | $49M | +14% y/y |
| Advanced Polymer Technologies EBITDA margin · Advanced Polymer Technologies · Q2-2026 | 22.7% |
Guidance
FY2026 net sales $1.05-1.15B; adjusted EBITDA $380-400M; diluted adjusted EPS $5.00-5.45; free cash flow $220-245M ex-litigation
Raises full-year adjusted EBITDA and EPS guidance after strong Q2, but maintains measured view on H2.
Risks flagged
Litigation settlement payment of $113.2M impacted operating cash flow
“driven by a $113.2 million litigation settlement payment” · word for word
Measured outlook for second half due to dynamic operating environment
“our outlook for the second half remains measured given the dynamic operating environment” · word for word
7 May 202610-QNet sales $258M (+4% y/y); Gross profit $116M (+4% y/y); Net income from continuing operations $23M (-20% y/y); Guidance: FY2026 net sales $1.05B-$1.15B; Adj. EBITDA $370M-$395Mopen
Figures in the filing · each found in the filing text
| Net sales · Q1-2026 | $258M | +4% y/y |
| Gross profit · Q1-2026 | $116M | +4% y/y |
| Net income from continuing operations · Q1-2026 | $23M | -20% y/y |
| Adjusted EBITDA from continuing operations · Q1-2026 | $92M | +0% y/y |
| Performance Materials segment net sales · Performance Materials · Q1-2026 | $155M | +6% y/y |
| Performance Materials segment EBITDA · Performance Materials · Q1-2026 | $92M | +10% y/y |
| Performance Chemicals segment net sales · Performance Chemicals · Q1-2026 | $58M | -1% y/y |
| Performance Chemicals segment EBITDA · Performance Chemicals · Q1-2026 | $600000.00 | -90% y/y |
| Advanced Polymer Technologies segment net sales · Advanced Polymer Technologies · Q1-2026 | $44M | +5% y/y |
| Advanced Polymer Technologies segment EBITDA · Advanced Polymer Technologies · Q1-2026 | $8M | -44% y/y |
Guidance
FY2026 net sales $1.05B-$1.15B; Adj. EBITDA $370M-$395M
Reaffirmed FY2026 guidance; Performance Materials margins consistent with 2025; Performance Chemicals margins high-teens; APT margins ~20%.
Risks flagged
BASF litigation cash outflow
“On March 13, 2026, we entered into an agreement with BASF, providing for the payment of: (1) the judgment, plus post-judgment interest, in the amount of $97.0 million and (2) $16.2 million to resolve BASF's claim for attorneys' fees and costs, and made such payments on April 1, 2026.” · word for word
Performance Chemicals margin collapse
“Segment EBITDA margin was 1.0% compared to 9.8% in the prior year.” · word for word
Road Markings competitive pressure
“Sales in Road Markings declined 10 percent, driven by continued competitive pressure impacting volumes, while pricing remained stable.” · word for word
APT segment margin decline
“Segment EBITDA margin was 17.2% compared to 32.2% in the prior year.” · word for word
6 May 20268-K · 2.02Net Sales $258M (+4% y/y); Net Income from Continuing Operations $23M (-20% y/y); Adjusted Earnings from Continuing Operations $41M (+12% y/y); Guidance: FY2026 net sales $1.05B-$1.15B, adjusted EBITDA $370M-$395M, adjusted EPS $4.70-$5.20,earningsopen
Figures in the filing · each found in the filing text
| Net Sales · Q1-2026 | $258M | +4% y/y |
| Net Income from Continuing Operations · Q1-2026 | $23M | -20% y/y |
| Adjusted Earnings from Continuing Operations · Q1-2026 | $41M | +12% y/y |
| Adjusted EBITDA from Continuing Operations · Q1-2026 | $92M | 0% y/y |
| Adjusted EBITDA Margin · Q1-2026 | 35.5% | |
| Diluted EPS · Q1-2026 | $0.65 | -18% y/y |
| Adjusted Diluted EPS · Q1-2026 | $1.15 | +14% y/y |
| Operating Cash Flow · Q1-2026 | $-2M | |
| Free Cash Flow · Q1-2026 | $-12M | |
| Share Repurchases · Q1-2026 | $52M |
Guidance
FY2026 net sales $1.05B-$1.15B, adjusted EBITDA $370M-$395M, adjusted EPS $4.70-$5.20, FCF $215M-$245M (excl. $113.2M litigation payment)
Reaffirmed full-year guidance after divestitures; strong Performance Materials offset by headwinds in Chemicals and APT; leverage reduction and buybacks support shareholder returns.
Risks flagged
Litigation settlement with BASF includes $16.2M charge in Q1; additional $113.2M pre-tax payment expected in 2026.
“includes $22.7 million of pre-tax special charges, inclusive of a $16.2 million charge related to the reimbursement of legal fees payable to BASF as part of the final settlement of the outstanding litigation” · word for word
Performance Chemicals Road Markings facing competitive pressure impacting volumes.
“Sales in Road Markings declined 10 percent, driven by continued competitive pressure impacting volumes, while pricing remained stable.” · word for word
Advanced Polymer Technologies EBITDA down 44% due to inventory build timing and planned outages.
“Segment EBITDA for the quarter was $7.6 million compared to $13.6 million in the prior year due primarily to an inventory build in the first quarter of 2025, in anticipation of a material planned outage in the second quarter 2025.” · word for word
4 May 20268-K · 5.02, 5.07Reported the departure of a director or principal officer (CEO/CFO change); submitted matters to a vote of security holdersopen
Risks flagged
Dilution risk from additional equity compensation shares.
“Amendment to increase authorized shares under the Ingevity Corporation 2025 Omnibus Incentive Plan”
30 Mar 20268-K · 1.01, 2.03Ingevity amended its credit agreement, reducing revolver commitments from $1B to $750M, extending maturity by 5 years, and repaying $512.1M in outstanding loans.open
Risks flagged
Reduced credit facility size may limit future borrowing capacity.
“decrease the aggregate amount of the commitments thereunder from $1 billion to $750 million” · word for word
17 Mar 2026DEF 14AProxy statement proposing amendment to increase authorized shares under the 2025 Omnibus Incentive Plan by 580,000 shares.open
Figures in the filing · each found in the filing text
| Total Net Sales · FY2025 | $1.29B | -8% y/y |
| Total Adjusted EBITDA · FY2025 | $398M | +10% y/y |
| Adjusted EBITDA Margin · FY2025 | 30.8% | |
| Free Cash Flow · FY2025 | $274M | +436% y/y |
| Net Sales from Continuing Operations · FY2025 | $1.17B | |
| Net Sales from Discontinued Operations · FY2025 | $122M | |
| Adjusted EBITDA from Continuing Operations · FY2025 | $373M | -1% y/y |
| Adjusted EBITDA from Discontinued Operations · FY2025 | $25M | |
| Company STIP-Adjusted EBITDA · FY2025 | $389M | +5% y/y |
| Company STIP-Adjusted Revenue · FY2025 | $1.28B |
Risks flagged
Low insider ownership
“Excluding Mr. Woodcock, who departed the Company as of July 1, 2025, directors and executive officers as a group beneficially own less than 1% of the Common Stock outstanding as of March 2, 2026.” · word for word
26 Feb 202610-KNet sales - Performance Materials $607M (-0% y/y); Net sales - Performance Chemicals $400M (-0% y/y); Net sales - Advanced Polymer Technologies $160M (-15% y/y)open
Figures in the filing · each found in the filing text
| Net sales - Performance Materials · Performance Materials · FY2025 | $607M | -0% y/y |
| Net sales - Performance Chemicals · Performance Chemicals · FY2025 | $401M | -0% y/y |
| Net sales - Advanced Polymer Technologies · Advanced Polymer Technologies · FY2025 | $160M | -15% y/y |
Risks flagged
BASF lawsuit judgment
“On September 15, 2021, a jury in the Delaware Proceeding issued a verdict in favor of BASF on the BASF Counterclaims and awarded BASF damages of approximately $28.3 million, which will be trebled under U.S. antitrust law to approximately $85.0 million.” · word for word
Dependence on third-party critical services
“We are dependent upon third parties for the provision of certain critical operating services, primarily utilities and related services (depending on the site, e.g., compressed air, energy, water, wastewater treatment, hydrogen peroxide), at our plants in Covington, Virginia, and Warrington, United Kingdom.” · word for word
Raw material supply and pricing
“The Company purchases a variety of raw materials from third parties for its manufacturing operations, including, but not limited to, hardwood sawdust, phosphoric acid, ethylene amines, tall oil fatty acid (TOFA), lignin, maleic/fumaric acid, hydrogen peroxide, cyclohexanone, and ethoxylates.” · word for word
Seasonality and weather sensitivity
“roughly 70 to 75 percent of revenue is generated between April and September.” · word for word
Labor union negotiations
“The CBA at our Covington, Virginia Plant with the Covington Paperworkers Union Local 675, affiliated with the Association of Western Pulp and Paper Workers expired on December 1, 2025.” · word for word
25 Feb 20268-K · 2.02, 7.01Total net sales (continuing and discontinued) $1.30B (-8% y/y); Net sales from continuing operations $1.20B (-3% y/y); Net loss $-167Mearningsopen
Figures in the filing · each found in the filing text
| Total net sales (continuing and discontinued) · FY2025 | $1.30B | -8% y/y |
| Net sales from continuing operations · FY2025 | $1.20B | -3% y/y |
| Net loss · FY2025 | $-167M | |
| Total adjusted EBITDA (continuing and discontinued) · FY2025 | $398M | +10% y/y |
| Adjusted EBITDA from continuing operations · FY2025 | $373M | 0% y/y |
| Adjusted EBITDA margin (continuing ops) · FY2025 | 31.9% | |
| Operating cash flow · FY2025 | $331M | |
| Free cash flow · FY2025 | $274M | |
| Net leverage · FY2025 | $2.60 | |
| Diluted adjusted EPS from continuing operations · FY2025 | $4.13 | +2% y/y |
Risks flagged
Non-cash impairment charges of $293.1M in APT and Road Markings indicate potential asset value concerns.
“$293.1 million in non-cash pre-tax special charges, related to Advanced Polymer Technologies and Road Markings” · word for word
Indirect tariff impacts weighing on APT demand.
“indirect tariff impacts weighed on demand in key customers' end markets” · word for word
5 Jan 20268-K · 1.01, 2.01, 7.01Cash consideration at closing $110M; Contingent consideration range $19Mopen
Figures in the filing · each found in the filing text
| Cash consideration at closing · 2026-01-01 | $110M | |
| Contingent consideration range · 2026-01-01 | $19M |
Risks flagged
Contingent consideration may not materialize if performance milestones are not met.
“potential contingent consideration ranging from $0 to $19 million, subject to the achievement of future business performance milestones” · word for word
8 Dec 20258-K · 5.02, 7.01Reported the departure of a director or principal officer (CEO/CFO change); issued a Regulation FD disclosure (forward guidance or material update)open
Risks flagged
Departure of Performance Chemicals president could indicate ongoing restructuring in that segment.
“Richard White, Senior Vice President and President, Performance Chemicals, will depart the Company on May 1, 2026” · word for word
8 Dec 20258-K · 7.01Stock repurchases in Q4 2025 $30Mopen
Figures in the filing · each found in the filing text
| Stock repurchases in Q4 2025 · Q4-2025 | $30M |
Risks flagged
Strategic alternatives may not result in a transaction; uncertainty around APT and Road Markings.
“The company cannot ensure that its strategic review will result in one or more transactions” · word for word
1 Dec 20258-K · 7.01Sale price $110Mopen
Figures in the filing · each found in the filing text
| Sale price · 2025-09-03 | $110M |
Risks flagged
Transaction expected to close by early 2026; subject to customary conditions.
“The Divestiture is expected to close by early 2026” · word for word
6 Nov 202510-QQ3 2025 results show mixed segment performance; full-year 2025 net sales and Total Adjusted EBITDA guidance revised downward due to continued pressure on Advanced Polymer Technologies from tariffs and weak demand.open
Figures in the filing · each found in the filing text
| Net sales · Q3-2025 | $333M | -0% y/y |
| Gross profit · Q3-2025 | $134M | +2% y/y |
| Net income (loss) from continuing operations · Q3-2025 | $41M | -14% y/y |
| Adjusted EBITDA from continuing operations · Q3-2025 | $110M | +2% y/y |
| Total Adjusted EBITDA · Q3-2025 | $121M | +14% y/y |
| Performance Materials Net sales · Performance Materials · Q3-2025 | $155M | +3% y/y |
| Performance Materials Segment EBITDA · Performance Materials · Q3-2025 | $80M | -1% y/y |
| Performance Chemicals Net sales · Performance Chemicals · Q3-2025 | $140M | +5% y/y |
| Performance Chemicals Segment EBITDA · Performance Chemicals · Q3-2025 | $25M | +2% y/y |
| Advanced Polymer Technologies Net sales · Advanced Polymer Technologies · Q3-2025 | $38M | -22% y/y |
Guidance
FY2025 net sales guided to $1.25B-$1.35B (revised down); Total Adjusted EBITDA guided to $390M-$405M (revised down)
Full-year 2025 guidance revised downward due to continued pressure on Advanced Polymer Technologies from indirect tariffs and competitive dynamics.
Risks flagged
Advanced Polymer Technologies demand pressure
“Advanced Polymer Technologies Net sales decreased 22 percent compared to the prior year quarter reflecting continued pressure from indirect tariff impacts that depressed demand in customers’ end markets, continued weak industrial demand, and increased competition in China.”
Guidance revision
“We are revising our 2025 outlook for Net sales, inclusive of both continuing and discontinued operations, to between $1.25 billion and $1.35 billion. We expect Total Adjusted EBITDA, inclusive of both continuing and discontinued operations, to be between $390 million and $405 million.” · word for word
Competitive pressure in Performance Chemicals
“Segment EBITDA margin was down to 17.7%, primarily due to lower pricing in road markings products within our road technologies product line to address competitive pressures.” · word for word
LIFO charges impacting gross profit
“Gross profit increase of $2.3 million was driven primarily by decreased manufacturing costs of $5.4 million, favorable foreign currency exchange of $2.8 million, favorable pricing and sales mix of $0.5 million, and favorable sales volume of $0.2 million. This increase was partially offset by LIFO charges of $6.6 million.” · word for word
5 Nov 20258-K · 2.02Total net sales (continuing and discontinued) $362M (-4% y/y); Net sales from continuing operations $333M (+0% y/y); Net income from continuing operations $41M; Guidance: Total net sales $1.25B-$1.35B; Total adjusted EBITDA $390M-$405Mearningsopen
Figures in the filing · each found in the filing text
| Total net sales (continuing and discontinued) · Q3-2025 | $362M | -4% y/y |
| Net sales from continuing operations · Q3-2025 | $333M | 0% y/y |
| Net income from continuing operations · Q3-2025 | $41M | |
| Total adjusted EBITDA (continuing and discontinued) · Q3-2025 | $121M | +14% y/y |
| Adjusted EBITDA from continuing operations · Q3-2025 | $110M | +2% y/y |
| Adjusted EBITDA margin (continuing ops) · Q3-2025 | 33.1% | |
| Operating cash flow · Q3-2025 | $130M | |
| Free cash flow · Q3-2025 | $118M | |
| Net leverage · Q3-2025 | $2.70 | |
| Share repurchases in Q3 · Q3-2025 | $25M |
Guidance
Total net sales $1.25B-$1.35B; Total adjusted EBITDA $390M-$405M
Guidance cut reflects APT weakness from tariff impacts and competitive pressures.
Risks flagged
Continued pressure from indirect tariff impacts and competitive pressures in APT, delaying recovery.
“continued pressure from indirect tariff impacts that depressed demand in customers’ end markets, continued weak industrial demand and increased competition in China” · word for word
Ingevity Corporation — questions
- What did Ingevity Corporation file recently?
- 18 SEC filings in the last 12 months. Latest: 10-Q on 2026-07-30 — Ingevity reported Q2 2026 net sales of $314.1 million, down 5% year-over-year, but adjusted EBITDA rose 14% to $115 million, and full-year guidance was raised.
Every figure on this page comes from Ingevity Corporation's own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.